Business Context and Reporting Period
Company: W.H. Brady Co. (Brady Corp)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended July 31, 1995
Business Overview: Brady develops, manufactures, and sells identification, labeling, and marking systems, as well as specialty tapes, utilizing surface chemistry, adhesives, and graphics technologies. The company operates 12 manufacturing facilities in the U.S. and six in foreign countries, serving industrial, commercial, and consumer markets globally.
Key Financial Metrics
Note: Specific consolidated revenue, net income, cash flow, and debt figures are incorporated by reference to the 1995 Annual Report (Pages 18-34) and are not explicitly detailed in the provided text. The following metrics are available from the filing text:
- Research & Development (R&D) Spend: $10.4 million (Fiscal 1995), compared to $10.3 million in 1994 and $12.1 million in 1993.
- International Sales: 41.1% of total sales (Fiscal 1995), up from 37.1% in 1994 and 32.0% in 1993.
- Backlog: $14.6 million as of July 31, 1995 (down from $17.4 million in 1994).
- Customer Concentration: No single customer accounted for more than 2.0% of sales in Fiscal 1995.
- Dividends (Class A Common Stock): Quarterly dividends increased to $0.30 per share in the first quarter of Fiscal 1996, up from $0.20 per share in the fourth quarter of Fiscal 1995.
- Stock Performance: Class A Common Stock price increased from $41.50 to $71.375 during Fiscal 1995.
Material Changes vs. Prior Period
- Revenue Growth: Management commentary indicates sales increased by $58.5 million (22.9%) compared to the prior year.
- Profitability: Profits increased by $9.4 million (50.5%) compared to the prior year.
- International Expansion: International sales grew significantly, rising from 37.1% of total sales in 1994 to 41.1% in 1995.
- Backlog Reduction: Firm backlog orders decreased by approximately $2.8 million year-over-year, from $17.4 million to $14.6 million.
- Executive Leadership: Katherine M. Hudson joined as President, CEO, and Director in January 1994. Donald P. DeLuca was promoted to Senior Vice President in August 1994.
- Divestitures: The company successfully divested the Nameplate Division of BUSA, Inc., Brady Medical Products Co., and certain real estate.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Management attributes strong performance to increased sales and profits, successful divestitures, and a focus on value-enhancing growth. The company aims for a significant portion of sales to come from products introduced within the past five years. The Compensation Committee notes that executive pay is tied to shareholder value enhancement, with bonuses reflecting the 50.5% profit increase and significant stock price appreciation.
Risks and Contingencies:
- Competition: Markets are highly competitive with fragmented competitors ranging from small firms to major global adhesive and electrical product companies.
- International Operations: Risks include currency fluctuations, exchange control regulations, and international relations affecting foreign operations.
- Raw Materials: While not dependent on a single supplier, the company relies on paper, plastics, metals, and chemicals.
- Environmental: Manufacturing processes use evaporative organic solvents. The company has invested in emission controls (e.g., $393,000 in incineration equipment over three years) and reformulated products to water-based emulsions.
- Patents: While the company holds patents on adhesive chemistry and electronics, rapid technology evolution may limit their long-term value.
Investor Verification Checklist
- Consolidated Financial Statements: Verify total revenue, net income, operating cash flow, and total debt figures in the 1995 Annual Report (Pages 22-34), as these specific numbers are not in the 10-K text provided.
- Dividend Sustainability: Confirm the company's cash flow position supports the recent increase in quarterly dividends to $0.30 per share.
- Backlog Trends: Investigate the reasons for the 16% decline in backlog orders ($17.4M to $14.6M) and its impact on future revenue recognition.
- Executive Compensation: Review the Supplemental Executive Retirement Plans (SERP) for CEO Katherine M. Hudson and CFO Donald P. DeLuca, which include significant deferred compensation and acceleration clauses upon change of control.
- International Exposure: Assess the impact of currency fluctuations on the 41.1% of sales generated internationally.